| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | DWI62G0P59 |
| InChI Key | BTGNGJJLZOIYID-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H22N2O7S |
| Molecular Weight | 434.47 |
| AlogP | 2.25 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 138.87 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 30.0 |
| Primary Target | |
|---|---|
| elastase, neutrophil expressed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S1A subfamily
|
- | 10-136 | - | 37-200 | - |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Acute Lung Injury; Lung Injury; Respiratory Distress Syndrome, Adult; Respiratory Distress Syndrome, Newborn; Wounds and Injuries | Phase 1/Phase 2 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 127373-66-4 |
| ChEBI | 135704 |
| ChEMBL | CHEMBL76688 |
| DrugBank | DB12863 |
| DrugCentral | 2452 |
| EPA CompTox | DTXSID9048304 |
| FDA SRS | DWI62G0P59 |
| Guide to Pharmacology | 6441 |
| PubChem | 107706 |
| SureChEMBL | SCHEMBL123221 |
| ZINC | ZINC000021298097 |